Table 1 Utilization of ACMG criteria and knowledgebase in PathoMAN variant curation

From: Toward automation of germline variant curation in clinical cancer genetics

Category

ACMG criteria

Utilization of ACMG criteria in PathoMAN’s variant classification

Literature and other sources

PVS1

Tier 1 variants (frameshift, truncating, essential splice, and initiation codon) in curated list of  tumor suppressor genes and cancer predisposition genes and not in their last exon

Public databases

PS1

Missense variant (HGVS protein change) in ClinVar with review status ≥2 irrespective of the genomic alternative allele

De novo data

PS2

User input

Public databases; functional data

PS3

Variant in list of pathogenic variants knowledgebase aggregated from literature with functional evidence, public database with loss of function reports, tier 1 variants in ClinVar reported with review status ≥2 and missense variants reported by ENIGMA

Population frequency data

PS4

Fisher’s case–control test odds ratio >3 and Pval <0.05 against ExAC noTCGA and gnomAD population of interest (applies to variants with BA1, BS1, BS2, and PM2 equal to 0)

Public databases

PM1

Amino acid residue in protein’s domain or residue for signaling or protein–protein interaction or in active site from Uniprot

Population frequency data

PM2

Variant absent from ExAC noTCGA or gnomAD

Allelic/genotypic data

PM3

Not used in the current version

Public databases

PM4

In-frame ins/del or stoploss in a nonrepetitive region from University of California–Santa Cruz (UCSC) Genome Browser

Public databases

PM5

Missense variant in ClinVar with review status  ≥2 irrespective of the alternative amino acid change at the same position as that of the reported pathogenic variant in ClinVar

De novo data

PM6

User input

Segregation data

PP1

User input

Public databases

PP2

Variant in gene with significant pathogenic missense burden in ClinVar

Genomic annotation and computational predictive data

PP3

In silico predictors agree on pathogenicity or deleteriousness of the variant

Other (disease specific)

PP4

Not used in the current version

Public databases

PP5

Variant in ClinVar with review status <2 and pathogenic without conflicts

Population frequency data

BA1

Variant seen in ExAC noTCGA or gnomAD with AF >5%

Population frequency data

BS1

Variant seen in ExAC noTCGA or gnomAD with AF between 1% and 5%

Population frequency data

BS2

Variant seen in ExAC noTCGA or gnomAD general population in homozygous form

Public databases; functional data

BS3

Variant in list of benign variants knowledgebase aggregated from literature with functional evidence, public database with loss of function reports, tier 1 variants in ClinVar reported with review status ≥ 2 and missense variants reported by ENIGMA

De novo data

BS4

User input

Public databases

BP1

Variant in gene with significant benign missense burden in ClinVar

Allelic/genotypic data

BP2

Not used in the current version

Public databases

BP3

In-frame ins/del or stop loss in a repetitive region from UCSC Genome Browser

Genomic annotation and Computational predictive data

BP4

In silico predictors agree on benignity or tolerance of the variant

Other (disease specific)

BP5

Not used in the current version

Public databases

BP6

Variant in ClinVar with review status <2 and benign without conflicts

Genomic annotation and computational predictive data

BP7

Synonymous variant with dbscSNV adaptive boosting and random forest score <0.6

  1. ACMG American College of Medical Genetics and Genomics, AF allele frequency.